Dr. Jeffrey Trent Awarded Mider Lectureship

Dr. Jeffrey Trent, President and Scientific Director-elect of The Translational Genomics Research Institute

PHOENIX, Wednesday, Oct. 9 - Dr. Jeffrey Trent, President and Scientific Director-elect of The Translational Genomics Research Institute, today was awarded the G. Burroughs Mider lectureship for his achievements in research at the National Institutes of Health's, National Human Genome Research Institute. This award is made annually to an NIH scientist who has made a significant contribution to the biomedical research eminence of NIH. The lectureship was presented by NIH director Dr. Elias Zerhouni, on the advice of the NIH Scientific Directors

The lectureship recognizes outstanding scientific achievements that bring credit to the NIH, said Dr. Michael Gottesman, Deputy Director for Intramural Research

Mider lecturer Dr. Jeffrey Trent (r) meets with NIH director Dr. Elias Zerhouni before the talk in the NIH Masur Auditorium.

Trent delivered the Mider Lecture on the topic of "Integrating Genetics, Genomics and Biology of Malignant Melanoma." He detailed his pioneering work in defining the molecular pathology of malignant melanoma, and showing how the development of molecular fingerprints could be used to predict response to treatment.

Trent was introduced by Zerhouni who emphasized the innovative nature of Trent's science and the important potential clinical impact of his work.

The Mider lecture is named in memory of G. Burroughs Mider, former Director of Laboratories and Clinics at NIH.


About TGen
The Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org.

Press Contact:
Steve Yozwiak
TGen Senior Science Writer
[email protected]

Media Contact

RSS Feed